Life-extension therapy: Asprin (acetylsalicylic acid (ASA), one of the commonly used drugs in the treatment of Pain, fever and inflammation, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 8/January/2017, 11.41 pm

Molecular therapy for Myocardial Infarction: Simvastatin (brand name: Zocor), a lipid-lowering medication, inhibits DNA damage responses, increases telomerase expression, inhibits telomere shortening, and promotes cardiomyocyte survival after myocardial infarction via up-regulation of PNUTS, 8/January/2017, 11.26 pm
January 8, 2017
Cardiac rejuvenation therapy: SNAI2/SLUG, a protein that promotes epithelial-to-mesenchymal transition, suppresses tumor suppressor INK4a/p16 expression, and inhibits dilated cardiomyopathy and heart failure via up regulation of its target gene, 8/January/2017, 11.58 pm
January 8, 2017
Show all

What they say?

A study from the Institute of Healthy Ageing, Centre for Diabetes and Endocrinology, Department of Medicine, University College London, London WC1E 6JJ, UK shows that “Ribosomal protein S6 kinase 1 signaling regulates mammalian life span.” This study was published in the 2 October 2009 issue of the Journal “Science” (I.F: 31.477 ) by Prof Dominic J. Withers, Dr. Selman C and others.


What we say

On the foundation of this interesting finding, Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports, for the first time, that:  Life-extension therapy: Asprin (acetylsalicylic acid (ASA), one of the commonly used drugs in the treatment of Pain, fever and inflammation, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span


Research findings to Therapeutic opportunity: 

Asprin, by  decreasing  the expression of its target gene, it may suppress Ribosomal protein S6 kinase 1 (p70S6 Kinase) expression. Thereby, it may promote: (1) resistance to bone, immune, and motor dysfunction; (2) insulin sensitivity; and (3) longevity (fig. 1).  

asprin-inhibits-p70-s6-kinase-expression-and-extends-lifespan

Fig 1. Asprin may function as a longevity promoter. Asprin (Acetylsalicylic acid), by suppressing the expression of p70 S6 Kinase, it may extend mammalian lifespan.

 

[easy_payment currency=”USD”]

Thus, pharmacological formulations encompassing Asprin either alone or in combination with any of the known longevity-promoting compound(s) may be used to extend the lifespan of an individual (fig. 1).


Details of the research findings: 

Idea Proposed/Formulated (with experimental evidence) by:

Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Undisclosed Information: How Asprin decreases the expression of p70 S6 Kinase and extends mammalian life span?

# Research cooperation

Amount: $100 #


References:

CitationBoominathan, L., Life-extension therapy: Asprin (acetylsalicylic acid (ASA), one of the commonly used drugs in the treatment of Pain, fever and inflammation, inhibits the expression of Ribosomal protein S6 kinase 1 (p70S6 Kinase) and extends mammalian life span, 8/January/2017, 11.41 pm, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org or newbioideas.com/

Courtesy: When you cite drop us a line at info@genomediscovery.org

Comments are closed.